Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gaulard

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Leukemia|May 8, 2009
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphomaP Coppo, V Gouilleux-Gruart, Y Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'AdulteC Haioun, E Lepage, C Gisselbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte studyC Haioun, E Lepage, C Gisselbrecht, et al.
Leukemia|October 15, 2010
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axisC Pangault, P Amé-Thomas, P Ruminy, et al.
Leukemia|May 14, 2009
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesA Carbonnelle-Puscian, C Copie-Bergman, M Baia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'AdulteD Wendum, C Sebban, P Gaulard, et al.
Blood|March 21, 1998
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localizationB Arnulf, C Copie-Bergman, M H Delfau-Larue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2008
L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literatureA Jaccard, B Petit, S Girault, et al.
Mucosal Immunology|July 3, 2014
Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patientsA Kök, L Hocqueloux, H Hocini, et al.
Blood|September 9, 2000
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probesJ Dierlamm, M Baens, M Stefanova-Ouzounova, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Leukemia|May 8, 2009
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphomaP Coppo, V Gouilleux-Gruart, Y Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'AdulteC Haioun, E Lepage, C Gisselbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte studyC Haioun, E Lepage, C Gisselbrecht, et al.
Leukemia|October 15, 2010
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axisC Pangault, P Amé-Thomas, P Ruminy, et al.
Leukemia|May 14, 2009
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesA Carbonnelle-Puscian, C Copie-Bergman, M Baia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'AdulteD Wendum, C Sebban, P Gaulard, et al.
Blood|March 21, 1998
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localizationB Arnulf, C Copie-Bergman, M H Delfau-Larue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2008
L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literatureA Jaccard, B Petit, S Girault, et al.
Mucosal Immunology|July 3, 2014
Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patientsA Kök, L Hocqueloux, H Hocini, et al.
Blood|September 9, 2000
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probesJ Dierlamm, M Baens, M Stefanova-Ouzounova, et al.
Pageof 18